Standalone and consolidated audited financial results for the quarter and year ended 31.03.2025 were approved by the Board in their 01/2025-26 Board meeting held on 21st May 2025. An extract ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medi-Caps Limited has submitted to BSE the newspaper clippings of its audited financial results for Q4 FY25 and full FY25, which were approved by the Board on 21st May 2025 and published in Free Press Journal (English) and Choutha Sansar (Hindi) on 23rd May 2025. On a standalone basis, Q4 revenue fell sharply to Rs 89.08 lakhs from Rs 196.92 lakhs YoY, while Q4 net profit dropped to Rs 7.61 lakhs from Rs 65.21 lakhs. Full-year standalone revenue declined to Rs 241.66 lakhs from Rs 696.35 lakhs, with net profit falling to Rs 55.51 lakhs from Rs 171.84 lakhs. Consolidated Q4 results showed a loss before tax of Rs 58.90 lakhs versus a profit of Rs 84.11 lakhs last year. Full-year EPS (standalone) dropped to Rs 0.45 from Rs 1.38, indicating weaker shareholder earnings.
A steep year-on-year decline in both revenue and profitability, along with a consolidated Q4 loss, is likely to be viewed negatively by shareholders and could weigh on the stock. However, the company has met its SEBI disclosure timelines by publishing results within the prescribed window.